NewLink Genetics linkp.com


Public list: BIO 2016 (619) Pharma Startups (4732) Cancer Therapeutics (1137)

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing immunotherapeutic products to improve cancer treatment options for patients and physicians.

Company (IPO / Went public)

Phone: 515-598-2925

Fax:

2503 South Loop Drive
Suite 5100
Ames, 50010
Iowa, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
NewLink Genetics $88.7M Nov 22, 2011
Metabasis Therapeutics $172.9M Jan 19, 2010
Bolder BioTechnology $3.5M Dec 5, 2008
See all 17 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related NewLink Genetics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 8 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 17 competitors